Naftidrofuryl oxalate

• CAT Number: I000039
• CAS Number: 3200-06-4
• Molecular Formula: C26H35NO7
• Molecular Weight: 473.56
• Purity: ≥95%
• Target: Neuronal Signaling
• Solubility: 10 mM in H2O
• Storage: -20°C
• IUPAC Name: 2-(diethylamino)ethyl 2-(naphthalen-1-ylmethyl)-3-(oxolan-2-yl)propanoate;oxalic acid
• InChI: InChI=1S/C24H33NO3.C2H2O4/c1-3-25(4-2)14-16-28-24(26)21(18-22-12-8-15-27-22)17-20-11-7-10-19-9-5-6-13-23(19)20;3-1(4)2(5)6/h5-7,9-11,13,21-22H,3-4,8,12,14-18H2,1-2H3;(H,3,4)(H,5,6)
• InChIKey: SSAJNPNVUYMUCI-UHFFFAOYSA-N
• SMILES: CCN(CC)CCOC(=O)C(CC1CCCO1)CC2=CC=CC3=CC=CC=C32.C(=O)(C(=O)O)O

Naftidrofuryl oxalate（Cat No.:I000039）is a vasoactive drug primarily used to improve blood circulation in conditions like intermittent claudication, a symptom of peripheral arterial disease (PAD). It works by dilating blood vessels, increasing blood flow, and enhancing oxygen delivery to tissues. Naftidrofuryl oxalate is believed to exert its effects by inhibiting serotonin receptors and affecting platelet aggregation, which can help reduce vascular resistance. It is typically administered orally and has been shown to improve walking distance and reduce pain in patients with PAD. Side effects are generally mild, with occasional gastrointestinal discomfort.